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Abstract
Objective: Gestational diabetes mellitus (GDM) is associated with substantial morbidity for mothers and their
offspring. While clinical and basic research activities on this important disease grow constantly, there is no concise
analysis of global architecture of GDM research. Hence, it was the objective of this study to assess the global
scientific performance chronologically, geographically and in relation to existing research networks and gender
distribution of publishing authors.
Study design: On the basis of the New Quality and Quantity Indices in Science (NewQIS) platform, scientometric
methods were combined with modern visualizing techniques such as density equalizing mapping, and the Web of
Science database was used to assess GDM-related entries from 1900 to 2012.
Results: Twelve thousand five hundred four GDM-related publications were identified and analyzed. The USA (4295
publications) and the UK (1354 publications) dominated the field concerning research activity, overall citations and
country-specific Hirsch-Index, which quantified the impact of a country’s published research on the scientific
community. Semi-qualitative indices such as country-specific citation rates ranked New Zealand and the UK at top
positions. Annual collaborative publications increased steeply between the years 1990 and 2012 (71 to 1157
respectively). Subject category analysis pointed to a minor interest of public health issues in GDM research. Gender
analysis in terms of publication authorship revealed a clear dominance of the male gender until 2005; then a trend
towards gender equity started and the activity of female scientists grew visibly in many countries. The country-
specific gender analysis revealed large differences, i.e. female scientists dominated the scientific output in the USA,
whereas the majority of research was published by male authors in countries such as Japan.
Conclusion: This study provides the first global sketch of GDM research architecture. While North-American and
Western-European countries were dominating the GDM-related scientific landscape, a disparity exists in terms of
research output between developed and low-resource countries. Since GDM is linked to considerable mortality and
morbidity of mothers and their offspring and constitutes a tremendous burden for the healthcare systems in
underserved countries, our findings emphasize the need to address disparities by fostering research endeavors,
public health programs and collaborative efforts in these nations.
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Background
Gestational diabetes mellitus (GDM) is defined as im-
paired glucose tolerance with onset or first recognition
during pregnancy [1]. Although GDM has been previously
regarded as “benign” [2] and usually resolves shortly after
delivery [3], the condition is associated with substantial
morbidity for mothers and their offspring [4–9]. Specific-
ally, fetuses exposed to an intrauterine high-glucose envir-
onment are at risk for macrosomia and adverse perinatal
outcomes such as injury or asphyxia during birth, infant
respiratory distress syndrome, hypoglycemia or hyperbilir-
ubinemia [10]. They are also prone to develop diabetes or
obesity later in life; epigenetic changes might be respon-
sible for this trans-generational transmission of diabetes
[11]. Pregnancies of affected patients are often compli-
cated by gestational hypertension or preeclampsia; rates
are also increased for delivery by cesarean section or sig-
nificant trauma during vaginal delivery [12]. Maternal
long-term morbidities include GDM recurrence in a sub-
sequent gestation and the development of type 2 diabetes
after 5 to 10 years [13].
Glucose intolerance during pregnancy is common in
almost every population around the globe [14]. Genetic,
social and environmental factors predispose women to
GDM, particularly females of Hispanic, African, Native
American, Asian, and Pacific Island ancestry [15, 16]. In
the United States of America (USA), approximately
200,000 new GDM cases are diagnosed each year trans-
lating to an annual economic burden of over $600 mil-
lion [17, 18]. GDM rates are estimated to be 10 % in the
USA, 5 % in the UK, and 2-6 % in other European coun-
tries [19]. These numbers are expected to further in-
crease due to growing obesity and sedentary lifestyle
[20]. GDM is also an aggravating problem in low-
resource countries: In 2015, the majority of 21 million
live births affected by hyperglycemia in pregnancy were
reported in low-and middle-income countries. South-
East Asia was leading the field with a prevalence of
24.2 %; in comparison, rates in Africa were reported up
to 11 % [21, 22]. In these countries, GDM poses a tre-
mendous burden: The condition leads to significant peri-
natal mortality, e.g. as shown in Kenya by a perinatal
mortality rate of 254 in 1000 [23]. Commonly, diagnosis
and treatment of the condition are challenging due to
insufficient financial resources and infrastructure as well
as climate and geography impacting the access and
availability of care. Also, the compliance of patients is
hampered by lack of education, religious beliefs, super-
stitions and fear of stigma [24].
Controversy still remains regarding the diagnosis and
treatment of GDM [16]. Scientific evidence is largely insuf-
ficient of which screening criteria are the most reliable to
diagnose GDM, when and who to screen, and whether par-
ticular screening practices of GDM would improve
maternal and perinatal outcomes significantly [25, 26].
Screening practices are not uniform worldwide leading to a
frequent under-diagnosis of GDM, incorrect assessment of
local prevalences as well as an under-management of af-
fected women [15]. Hence, GDM constitutes a major public
health concern. Uniform management criteria are crucial
for the global establishment of successful primary and sec-
ondary preventive strategies carried out in the framework
of international collaborations. In view of the burden GDM
creates worldwide, detailed knowledge on the global re-
search architecture of GDM is required for (1) individual
scholarship, (2) planning future scientific and public health
initiatives according to identified shortcomings, and (3) ob-
jective performance assessment in the field to supply deci-
sion makers with information concerning funding
strategies. This is a challenging task due to the vast number
of related scientific publications available. Therefore, scien-
tometric methods enable researchers to conduct a focused,
systematic and reliable analysis of journal articles regarding
their content and citations to describe trends in institutions
of origin and dissemination of published data. Specifically,
this ‘New Quality and Quantity Indices in Science’ (New-
QIS) project [27, 28] aimed to assess the scientific output
related to GDM regarding quantitative and qualitative as-
pects, geographical and chronological developments, exist-
ing research networks and gender analysis in a
standardized way using an in-depth study protocol comb-
ing scientometric tools and modern visualization tech-
niques including density equalizing mapping [29].
Methods
NewQIS platform
We employed the previously validated New Quality and
Quantity Indices in Science (NewQIS) platform to identify
all research published on GDM since 1900 [27, 28]. Our
search covered original articles but also publications such
as meeting abstracts and reviews and included clinical,
basic science and translational research conducted on ani-
mals or humans. In 2009, NewQIS was established as part
of an international study project [27, 28]. It encompasses
both scientometric and novel visualization techniques
such as density equalizing mapping projections (DEMP)
to illustrate research activity by anamorphic maps for the
purpose of benchmarking processes aiming to compare
qualitative and quantitative performance metrics of bio-
medical research [27, 28]. Since NewQIS started, numer-
ous studies have been performed in the fields of obstetrics
[30], public health and health policy development [31–35],
or internal medicine [36, 37].
Data source
Similar to previous studies, we used the Web of Science
database (WoS, Thomson Scientific) for data collection.
This resource enabled us to conduct a unique citation
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analysis in addition to the assessment of publication ac-
tivity [38, 39]. No research was performed involving hu-
man subjects or animals hence it was not required to
obtain IRB approval for this study.
Search strategy
NewQIS studies are based on unique search terms that
encompass the disease of interest. Hence, we generated
the GDM-specific search term “Topic = diabetes AND
(gestation* OR “pregnancy induced” OR “pregnancy as-
sociated” OR maternal)” to approximate the overall
number of published items. The term was applied in a
“Topic” search identifying the search term in the title,
abstract and author’s keywords. The analyzed timeframe
for GDM research covered the years between 1900 (01–
01) and 2012 (31–12). Results from 2013 onwards were
not considered due to incomplete data acquisition at the
time the study was performed.
Data analysis and categorization
According to the previously described workflow [27, 28],
we downloaded and saved all publications identified by
our search term in a Plain text format using the down-
load tool provided by the WoS. Then, an interim data-
base was created by collecting all metadata related to the
items. Based on these metadata, GDM-related publica-
tions were analyzed and categorized with respect to pub-
lication date, document type, country of origin,
language, source title, subject categories, authors, and
participating institutions. Also, citation information was
retrieved for each publication; the average number of ci-
tations per item (citation rate) and the modified Hirsch-
Index (h-Index) were calculated as semi-qualitative vari-
ables. We related the citation rate and h-Index, which
represents the impact of one author’s research output on
the scientific community, to the GDM-specific publica-
tion activity of single countries constituting a country-
specific citation rate and “modified” h-Index.
After transfer of the downloaded and unedited WoS
plain text data files to excel charts, the findings were il-
lustrated in diagrams and visualized by DEMPs. The
current DEMPs were based on the algorithm of Gastner
and Newman [29]. Here, the territories of the different
countries publishing on GDM were resized in propor-
tion to our selected variables. We used this technique to
draw a sketch of the global GDM research activities con-
cerning the distribution of country-specific numbers of
published items and average citation rates [29]. All in-
vestigated countries were categorized as high-income,
upper-middle and lower-middle income countries ac-
cording to the definition of the World Bank (http://
data.worldbank.org/country/).
Gender analysis
In order to determine gender aspects of global GDM re-
search, we calculated the proportion of male to female au-
thors (reflected by the male to female ratio, m:f ratio)
based on all authors’ names listed in the publications. We
conducted a manual search (utilizing websites, corre-
sponding addresses and social networks) if first names
were not gender-specific or quoted as initials. In particu-
lar, Asian names were difficult to assign to a specific gen-
der. To avoid imprecision, only countries were considered
with a minimum of 500 authors who published more than
700 items in total and whose author’s gender could clearly
be determined in over 50 % of names. This methodology
has been previously described in earlier research [29].
Analysis of cooperations
To analyze scientific co-operations between different
countries, author affiliations stated on the identified
GDM-related publications were analyzed as previously
described [38, 40]. Only countries that participated in
five or more collaborations were included in the analysis.
If at least two authors conducting research in two differ-
ent countries contributed to one GDM publication, this
relationship was defined as collaboration. We termed
collaborations involving two countries as bilateral and
collaborations involving three countries as trilateral co-
operations. To visualize the productivity of these co-
operations for each pair of countries a vector was calcu-
lated, which was proportional in line width and shade of
grey to the number of GDM-related collaborations [38,
40]. We also calculated the country-specific percentage
of collaborative publications among all published items
in high-income, upper-middle and lower-middle income
countries (Table 1) and assessed differences between
these groups by Student’s t-test. A p-value <0.05 was
regarded as statistically significant.
Analysis of publication output related to the number of
inhabitants
The research output of the ten most productive high-
income, eight upper-middle income and three lower-
middle income countries was related to the number of
inhabitants aiming to analyze a country’s scientific prod-
uctivity in the context of manpower. The following
index was calculated: publications/population-index:
number of publications/population in millions. We ob-




In total, 12,504 publications related to GDM research
were identified; 95.22 % of these were authored in Eng-
lish. The USA was the most productive county with
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4,295 publications (p: publications), followed by the
United Kingdom (UK, p: 1,354), Australia (p: 635),
Canada (p: 584), Italy (p: 550), Germany (p: 536), France
(p: 497), Sweden (p: 430), Israel (p: 367) and Spain (p:
366). This distribution of the global research productiv-
ity is depicted in the DEMP-analysis (Fig. 1a): Here, the
USA constitutes the scientific center with the clear ma-
jority of publications (p: 4,295), followed by Western
Europe. In contrast, major parts of Asia including Russia
and China, Africa and South America appear minimized
due to their extremely low scientific output, e.g. South
Africa (p: 38, Chile p: 90 and India p: 142).
Country citations
When we analyzed the total citation activity, the USA
was the leading nation with 93,567 citations, followed by
the UK with 44,443 citations, and Australia with 12,341
citations. Canada had 11,136 citations and Sweden
10,719 citations, followed by France (7,186 citations),
Germany (6,830 citations) and Italy (6,621 citations).
The Netherlands was ranked 9th with 5,823 citations
and Finland 10th with 5,580 citations.
DEMP illustrating the citation analysis (Fig. 1b) dem-
onstrates a similar picture to the DEMP analysis of total
publication activity (Fig. 1a). Some minor exceptions
were noted, i.e. Sweden occupied a higher proportion of
the world map. Overall, the Scandinavian countries held
a more pronounced position when citations were ana-
lyzed compared to publication activity.
Country specific h-Index
The calculation of the country specific h-Index demon-
strated a leading position of the USA with 125 GDM-
related publications being cited at least 125 times. The
USA was followed by the UK with a country specific h-
Index of 97, Canada (h-Index: 55), Sweden (h-Index: 53),
Australia (h-Index: 48), Germany (h-Index: 47) and
France (h-Index: 45). Italy had a country-specific h-
Index of 42 and Finland and Denmark both 41. Again,
countries from Asia, Africa, Eastern Europe, South and
Central America occupy only a minimized area on the
DEMP map corresponding with their extremely low
modified h-Indices (Fig. 2a).
Country citations rates
The country citation rate (CR) is a semi-qualitative meas-
ure (citations per publication of a country, with a thresh-
old of 30 publications per country) in contrast to absolute
Table 1 Publication output in relation to population size
Country Number of publications Collaborative publications Joint publications in % Population size P/P Index Country type
USA 4295 702 16.3 314,112,078 13.7 HI
UK 1354 459 33.9 63,700,300 21.3 HI
Australia 635 172 27.0 22,728,254 27.9 HI
Canada 584 162 27.7 34,754,312 16.8 HI
Italy 550 177 32.2 59,539,717 9.2 HI
Germany 536 161 30.0 80,425,823 6,7 HI
France 497 129 26.0 65,639,975 7.6 HI
Sweden 430 149 34.7 9,519,374 45.2 HI
Israel 367 105 28.6 7,910,500 46.4 HI
Spain 366 92 25.1 46,773,655 7.8 HI
China 231 65 28.1 1,350,695,000 0.2 UMI
Brazil 268 38 14.2 202,401,584 1.3 UMI
South Africa 38 13 34.2 52,341,625 0.7 UMI
Serbia 20 8 40.00 7,199,077 2.8 UMI
Jamaica 13 8 61.5 2,707,805 4.9 UMI
Thailand 27 9 33.3 67,164,130 0.4 UMI
Algeria 17 11 64.7 37,439,427 0.5 UMI
Tunisia 22 7 31.8 10,777,500 2.0 UMI
India 142 48 33.8 1,263,589,639 0.1 LMI
Egypt 25 15 60.0 856,009,902 0.02 LMI
Sri Lanka 13 6 46.2 20,328,000 0.6 LMI
We related the total numbers of publications to the population number of high-income (HI), upper-middle (UMI) and lower-middle income (LMI) countries
(publications/population-index(P/P Index): number of publications/population in millions). Also, the number of collaborative publications and the percentage of
these among the total publications are listed
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parameters such as the total publication and total citation
counts. In this analysis of GDM-specific research, New
Zealand was ranked first with a CR of 36.26 (4,859 cita-
tions and 134 publications). Again, the UK occupied the
second place with a CR of 32.82, followed by Sweden (CR
24.93), Belgium (CR 23.78), Netherlands (CR 23.77),
Switzerland (CR 22.48), and Finland (CR 21.81). The USA
was only ranked 8th with a CR 21.79 followed by Norway
(CR 20.55) and Australia (CR 19.43) (Fig. 2b).
Gender analysis
When the gender analysis of authors active in GDM re-
search was performed, an increase in the percentage of
female authorship occurred from 2005 onwards. In the
assessment of the 15 most productive countries, large
differences were present as demonstrated by 1107 female
versus 832 male scientists who authored all US-
American publications (m:f ratio of 0.8). In Canada, the
gender distribution was almost equal as seen by 134
Fig. 1 Density-equalizing map of global research activity related to gestational diabetes mellitus in the timeframe between 1900 and 2012. Colors
and territorial sizes indicate numbers of publications (a) as well as numbers of citations per country (b)
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female versus 131 male authors (m:f ratio of 1.0). In
striking contrast, 97 male versus 27 female scientists
(m:f ratio of 3.6) were identified for Japanese authors of
GDM-related publications (Fig. 3). Overall, we identified
males representing the largest proportion of scientists in
five of the 15 evaluated countries including the UK (201
males versus 174 females; m:f ratio of 1.2), Germany (90
males versus 70 females; m:f ratio of 1.3), France (75
males versus 65 females; m:f ratio of 1.2), Japan and
Austria (46 males versus 29 females; m:f ratio of 1.6). In
the USA, Australia (134 males versus 173 females; m:f
ratio of 0.8), Italy (114 males versus 127 females; m:f ra-
tio of 0.9), Sweden (49 males versus 66 females; m:f ratio
of 0.7), Spain (68 males versus 86 females; m:f ratio of
0.8), Brasil (72 males versus 134 females; m:f ratio of
0.5) and Finland (42 males versus 95 females; m:f ratio
Fig. 2 Density-equalizing map projections of semi-qualitative variables assessed for GDM-related research. a Country-specific Hirsch-index. b
Citation rate (citations per publication of a country, with a threshold of 30 publications per country)
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of 0.4), a higher percentage of women were active in
publishing GDM-specific research. An equal distribution
of female to male authors was seen for Canada and
Denmark (52 males versus 55 females; m:f ratio of 1).
Collaborative articles
In total, 1,261 of all publications were a result of inter-
national collaborations between two or more countries
(10,1 % of all publications). The annual number of col-
laborative publications increased steeply between the
years 1990 and 2012 (71 to 1157 respectively). Bilateral
cooperations issued 1,261 publications and were the
most common type, followed by trilateral collaborations
(195 publications). Cooperations between four countries
authored 41 items and collaborative efforts between five
countries created 21 publications. 15 publications were
issued by authors working in six different countries.
Again, the USA dominated this analysis with 702 collab-
orative articles (16.3 % of all US-American publications).
Most productive cooperations were established between
the USA and the UK (110 joint publications), followed
by the USA and Israel (83 publications), the USA and
Canada (69 publications) and the USA and Sweden (66
publications). The UK was part of 459 cooperations
(33.9 % of all UK publications), while Italy - as the third
most active collaborating country - issued 177 publica-
tions (32.2 % of all Italian publications). A spider chart
exemplifies the extent of cooperations between all inves-
tigated countries (Fig. 4).
We also assessed the percentage of collaborative publi-
cations among all country-specific publications as shown
in Table 1. On average, high-income countries published
29.5 %, upper-middle income countries 38.5 % and
lower-middle income countries 46.7 % items in a joint
effort. We found significant differences between the per-
centage of collaborative items among all country-specific
publications when we compared high-income to upper-
middle income as well as low-income countries: The
high-income countries issued less publications in joint
efforts than authors from upper-middle income (p:
0.042) or low-income countries (p: 0.001).
Subject area analysis
The subject categories of all GDM-related articles were
analyzed in five-year intervals from 1963 to 2012 with
regard to their percentage proportion in order to gain
insights into the field’s activity and scientific priorities
(Fig. 5). Overall, we documented a percentage increase
in the subject area ‘Endocrinology & Metabolism’. In the
period of 1963–1967, only a small proportion was attrib-
uted to this subject area. This grew over time, and from
1978 onwards this category dominated the research to-
gether with ‘Obstetrics and Gynecology’ (OB/GYN),
which was the second most applied subject category.
The percentage in the category “General and Internal
Medicine” decreased in relative numbers after 1972. Fur-
ther, the field diversified after 1973 and articles were
published in numerous new categories such as “Physi-
ology”, “Genetics and Heredity”, “Nutrition and Dietet-
ics” and “Public, Environmental and Occupational
Health”.
Fig. 3 Gender analysis of the 15 most publishing countries. The proportion of female and male authors as depicted here was assessed based on
the authors’ names listed in the publications
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Fig. 4 International cooperations. This spider chart exemplifies the extent of cooperations between the all investigated countries. Greyscale and
bar thickness indicate intensity of collaborations. Figures beside the country names represent the number of publications/number of
collaboration articles
Fig. 5 Subject areas. Relative proportions of the 10 most assigned subject areas illustrated in 5-year intervals between 1900 and 2012
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Analysis of publication output related to the number of
inhabitants
When GDM-specific research output was related to
population size, we documented the following ranking:
Israel was leading the analysis with 46.4 GDM-specific
publications per citizen, followed by Sweden (45.2
GDM-specific publications per citizen), Australia (27.9
GDM-specific publications per citizen), UK (21.3 GDM-
specific publications per citizen) and Canada (16.8
GDM-specific publications per citizen). The USA (13.7
GDM-specific publications per citizen) dropped to pos-
ition six among the 10 most productive high-income
countries. Very low indices were found for countries
with large population sizes such as China (0.2 GDM-
specific publications per citizen) and India (0.1 GDM-
specific publications per citizen) (Table 1).
Discussion
This study is the first detailed analysis of the global
GDM research architecture. It combines established
scientometric and density equalizing mapping tools [29]
and focuses on gender aspects of this important female
health issue. We identified 12,504 publications related to
GDM research, which have been authored since 1900.
The scientific output was dominated by the industrial-
ized North-American, Western European nations as well
as Israel; these nations commonly established scientific
collaborations leading to numerous publication of out-
standing quality. In contrast, many developing and
underdeveloped countries did not participate in research
or collaborative efforts dedicated to GDM.
Before going into detail, the following methodological
strengths and limitations need to be discussed. For our
analysis, we employed the NewQIS platform, which con-
stitutes a novel study tool that was specifically designed
for standardized, objective and reliable scientometric
analyses of research productivity based on a validated
protocol [27, 28]. Benefits of using this sophisticated
platform include the efficient evaluation of the scientific
progress chronologically and geographically, the
visualization of the results in expressive global maps as
well as the incorporation of unique investigations such
as the institution network analysis. As data source, we
preferred the WoS to the PubMed database because the
publications listed in the WoS are attached with a
broader range of easily accessible bibliographic data (e.g.
subject categories). Also, the WoS supports the Journal
Citation Reports, which are a WoS-specific feature to
extract detailed citation information for single index en-
tries [41]. Hereby, we could assess semi-qualitative vari-
ables, i.e. the country specific h-indices, enabling us to
evaluate the research productivity in a multifaceted way.
Therefore, we believe that the WoS is the most suited
database to address the presented research question.
However, we are well aware that entering the present
search term in the PubMed search function would have
lead to a different set of identified publications because
differing scientific journals are indexed in this particular
database. A methodological issue we identified in this
study is a language bias. 95.22 % of GDM-related publi-
cations were authored in English. Since the WoS has a
clear preference for English journals and many national,
non-English written journals are not enlisted by the
WoS, non-English items might be underrepresented in
our analysis. Therefore, we have to assume a bias to-
wards all anglophone countries such as the USA, UK
and Australia that needs to be taken into account when
interpreting the country-specific GDM research prod-
uctivity. However, we consider this particular language
bias as limited since all high quality research of non-
English speaking countries is commonly published in
English [42]. Also, 95 % of cited and 80 % of published
items related to a specific topic are indexed by the WoS
and therefore would have been incorporated in our ana-
lysis [43]. The third limitation is related to the complex-
ity of the gender analysis in the presented study. Since it
is not possible to discriminate between sexes for gender-
neutral or abbreviated names, i.e. for the Chinese au-
thors, we had to exclude publications originating from
China from this specific part of our analysis. However,
China did not belong to the top 15 most productive
countries, so the problem can be considered as minor.
When assessing the gender of the publishing scientists
in a country-specific manner, differences became evi-
dent: Whereas the USA seemed to contribute well to the
gender mainstreaming with a dominance of female au-
thors, other countries such as Japan do not seem to ad-
dress this issue with evident success, i.e. by the
establishment of specific programs supporting women.
Promoting women is important in a surgical specialty
such as OB/GYN: Presently, female physicians are in-
creasingly entering surgical professions [44, 45] although
surgery is still a male-dominated area with women
representing only 10–20 % of the workforce [45–47]. In
contrast to this development, the percentage of female
medical school faculty in surgical fields remains well
below the proportion of men [45, 48]. This indicates a
major disparity and disadvantage for females to become
promoted into higher academic ranks. Therefore, spe-
cific programs need to be established that address dis-
crimination in medicine and science. As shown for
GDM, Brazil - among other countries (e.g. the USA,
Australia, Italy) - serves as an impressive example sup-
porting the participation of female scientists in economy,
science and technology as numerous gender benchmark-
ing studies demonstrated [49]. We want to point out
that other nations like Japan should feel encouraged to
follow this nation’s lead.
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Overall, we identified the USA as the leading country
in GDM research: It was the most productive nation and
was involved in the majority of collaborative efforts. US-
American publications gained the highest number of ci-
tations and had the highest h-index. Countries that par-
ticipate in close collaborations with the USA such as
Canada seem to clearly benefit from this cooperation as
documented by Canada’s outstanding output and quality
in research. When the global GDM research activity is
compared to other fields of medicine, it can be stated
that the dominance of the USA is a common
phenomenon, e.g. as shown by Groneberg-Kloft [33].
The authors assessed the overall publication output in
the biomedical field related to 21 organ systems. Here,
the USA issued 1,893,800 of 5,527,558 publications in
50 years and showed the highest productivity. We be-
lieve the US-American dominance in the medical-
scientific field points to the excellent research conditions
and funding situation in this country. For GDM, we doc-
umented the following ranking regarding publication
productivity: After the USA the UK was ranked second,
Australia third, Canada 4th, Italy 5th, Germany 6th,
France 7th, Sweden 8th, Israel 9th and Spain 10th. We
related these results to other bibliometric studies in the
field of obstetrics, and a similar picture emerged. For
smoking and pregnancy, 10,043 publications were
assessed and the majority of items were authored by the
USA, the UK and Canada followed by other Northern
European nations [30]. In our study, it also became ap-
parent that Japan does not seem to focus on GDM re-
search with the same emphasis as put on other diseases.
This finding may be linked to the relatively low preva-
lence of GDM in Japan, which is documented at 2.9 %
[50].
We deduced the need to generate a systematic sketch
of the global GDM research architecture from the fact
that reliable data on GDM prevalences as well as on re-
lated perinatal mortality or morbidity are scarce in many
parts of the world. Since diagnostic criteria to identify
GDM are not standardized globally, it is difficult to
quantify and compare reported epidemiological data to
draw meaningful conclusions [24]. A recent study aimed
to investigate the prevalence and geographical patterns
of GDM in low-and middle-income countries [51]: The
local rates of GDM varied, no reliable geographical pat-
terns were confirmed, and prevalences were estimated
between 0.4 % and 24.3 % based on the criteria applied
(e.g. 1.50–15.5 % based on the American Diabetes Asso-
ciation criteria, 20.8 % based on the Australian Diabetes
in Pregnancy Society criteria, and 0.4–24.3 % based on
the World Health Organization criteria) [51]. Overall,
Vietnam, India and Cuba had the highest GDM rates,
and data from Africa were particularly limited, and re-
cords on maternal mortality due to GDM were sparse
[51]. It was concluded that the existing data are insuffi-
cient to build a clear picture of the burden of GDM in
low-and middle-income countries and that further re-
search is needed [51]. In addition to these recently pub-
lished results, our density equalizing mapping
projections also demonstrated that large parts of the
world-particularly affected by GDM-are characterized by
a low scientific productivity and need to increase sys-
tematic research activities to meet these obvious short-
comings. In this context, it cannot be recommended
that low-resource countries invest in expensive basic sci-
ence research, i.e. new pharmacologic approaches in
GDM management, but should be empowered to imple-
ment local public health programs and standardized
screening protocols. Unfortunately, the area of public
health does not merit strong interest as demonstrated by
our current subject area analysis. While there was a gen-
erally increased activity in public health research from
1963 to 2012, the overall interest in this area remained
low in comparison to other subject categories. Hence,
the present study may be used as a starting point to con-
vince supra-national funding agencies to allocate re-
sources to this extremely important area of medicine
that targets both pregnant women and their offspring.
Hunt and Schuller reviewed studies that examine the
prevalence of GDM and related trends with regard to
different populations. In this context, differences in the
local prevalence might correlate to GDM research activ-
ity: In low-risk populations, such as in Sweden, the
prevalence in population-based studies is lower than
2 %-even when universal testing is offered [52]. This
may lead to the assumption that GDM research is not
particularly focused upon in Sweden, which is a North-
ern European country with a relatively low population of
about 9.5 million inhabitants and relatively small active
research community [53]. In our analysis, exactly the op-
posite was true since Sweden belonged to the most ac-
tive and dedicated countries – particularly when related
to manpower - that also published high quality research
as demonstrated by a citation rate with 24.93 citations
per GDM publication. We hypothesize that these find-
ings are based on the unique scientific infrastructure
established in this country: Data can be acquired from
numerous large epidemiological databases, e.g. the
Swedish Birth register, enabling researchers to conduct
high quality, highly cited key epidemiologic studies.
Countries with high GDM prevalences and growing
obesity should have an interest to conduct research in
the field aiming to lower the burden of this condition
for the female inhabitants and their offspring. As shown
in our study, this correlation is particularly true for the
USA. However, countries located on the Asian (e.g. India
and China) and African continents - where the majority
of 21 million live births affected by gestational
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hyperglycemia are found and linked to significant mor-
tality and morbidity [22]- were not identified as particu-
larly active countries in GDM research. This finding
may result from the personal, institutional and national
challenges connected to conducting research in low-
resource settings [54]. Here, planning of research en-
deavors and resource allocation are often hindered due
to an unfavorable political climate; research is not a na-
tional priority [54]. Particularly, funding is limited and
largely dependent on non-governmental sources [54].
Also, common problems in these settings include lack of
an appropriate infrastructure and state-of–the art re-
search facilities [55]. Researchers themselves face diffi-
cult conditions such as poor earnings, lack of
recognition and subpar training opportunities, which
often lead to their migration abroad [56].
Although our study documented a higher percentage
of publications from upper- and lower-middle income
countries to be joint works in comparison to high-
income countries (38.5 % and 46.7 % versus 29.5 % re-
spectively), we deduce that collaborative efforts between
countries of different economic capabilities have to be
further increased to improve the research productivity of
low-resource nations. Challenges to establish these fruit-
ful collaborations are manifold and include cultural dif-
ferences, a diverging perspective regarding the conduct
of research and unrealistic assessment of the local re-
search capacity and resources [54]. Collaboration part-
ners have to be willing to overcome these knowing that
joint efforts in the global research arena allow the partic-
ipants to tap into global knowledge and provide ample
opportunities for personal development, successful re-
search funding, and facility improvement.
Numerous studies validated that hyperglycemia dur-
ing pregnancy translates into increased perinatal mor-
bidity for mother and child; these complications can
be avoided and lessened by the better detection and
management of the condition [57]. Hence, the world-
wide establishment of uniform screening and manage-
ment criteria is crucial for future successes. Further,
understanding the racial and ethnic disparities in
GDM diagnosis, management, and outcomes is also a
substantial step towards implementation of meaning-
ful policies, clinical decision making and patient
counseling leading to an improvement of maternal
and child health. In this context, we advocate to ad-
dress country-specific challenges and to focus on
close-knit networks and shared public health efforts.
Strengthened collaborations allow the exchange of
epidemiological data, ideas and resources between in-
dustrialized and low-resource nations and represent
an opportunity-and almost an ethical responsibility-to
strengthen research endeavors and to lower the bur-
den of GDM in underserved countries.
Conclusions
By analyzing quantitative and semi-qualitative aspects of
the scientific output related to GDM, we provided an ob-
jective assessment of the research performance in the
field. Also, the first sketch of the global research architec-
ture was presented. Clearly, the USA dominated most pa-
rameters. However, other countries that usually also
dominate the top five most productive countries such a
Japan, did not exhibit an extremely high publication activ-
ity in GDM compared to other fields of medicine. Many
low-resource countries that are affected by a considerable
burden by GDM are underrepresented in the global map
of GDM research. To lower the public health burden at-
tached to GDM and to tackle the existing disparities, dedi-
cated research needs to be tailored to apparent needs and
fostered by strengthening and funding collaborative efforts
between industrialized and underserved countries.
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